Highlight your achievements on People@HES-SO More info
PEOPLE@HES-SO – Directory and Skills inventory
PEOPLE@HES-SO – Directory and Skills inventory

PEOPLE@HES-SO
Directory and Skills inventory

Help
language
  • fr
  • en
  • de
  • fr
  • en
  • de
  • SWITCH edu-ID
  • Administration
« Back
Bochud Maëlle

Bochud Maëlle

Adjointe scientifique HES

Main skills

Fed batch culture

Process development

Recombinant protein

Microbiology

Project Management

Good Manufacturing Practices (GMP)

Biosafety officer

  • Contact

  • Teaching

  • Publications

  • Portfolio

Main contract

Adjointe scientifique HES

Haute école d'ingénierie et d'architecture de Fribourg
Boulevard de Pérolles 80, 1700 Fribourg, CH
HEIA-FR
BSc HES-SO en Chimie - Haute école d'ingénierie et d'architecture de Fribourg

2025

Hypoxia-induced conversion of sensory Schwann cells into repair cells is regulated by HDAC8
Scientific paper

Nadège Hertzog, Mert Duman, Bochud Maëlle, Valérie Brügger-Verdon, Maren Gerhards, Felicia Schön, Franka Dorndecker, Dies Meijer, Robert Fledrich, Ruth Stassart, Devanarayanan Siva Sankar, Jörn Dengjel, Sofía Raigón López, Claire Jacob

Nature Communications, 2025

Link to the publication

Summary:

After a peripheral nerve injury, Schwann cells (SCs), the myelinating glia of the peripheral nervous system, convert into repair cells that foster axonal regrowth, and then remyelinate or re-ensheath regenerated axons, thereby ensuring functional recovery. The efficiency of this mechanism depends however on the time needed for axons to regrow. Here, we show that ablation of histone deacetylase 8 (HDAC8) in SCs accelerates the regrowth of sensory axons and sensory function recovery. We found that HDAC8 is specifically expressed in sensory SCs and regulates the E3 ubiquitin ligase TRAF7, which destabilizes hypoxia-inducible factor 1-alpha (HIF1α) and counteracts the phosphorylation and upregulation of c-Jun, a major inducer of the repair SC phenotype. Our study indicates that this phenotype switch is regulated by different mechanisms in sensory and motor SCs and is accelerated by HDAC8 downregulation, which promotes sensory axon regeneration and sensory function recovery.

2019

Characterization of a quasi-enveloped, fast replicating hepevirus from fish and its use as hepatitis E virus surrogate
Scientific paper

Bochud Maëlle, Wolfram Schäfer, Nathan J. Roth, Carlos Ros

Journal of Virological Methods, 2019 , vol.  263, pp.  111-119

Link to the publication

Summary:

Hepatitis E virus (HEV) is an emerging concern for the safety of plasma-derived medicinal products. The lack of an efficient cell culture system hampers the studies on HEV biology as well as validation studies to test the capacity of virus reduction steps to clear HEV. Hence, a surrogate hepevirus that can efficiently replicate in cell culture is needed. Cutthroat trout virus (CTV) is a non-pathogenic fish hepevirus, which can replicate in cell culture to high titers. Under interferon inhibition, CTV replication reached up to 5 × 10^7 genome equivalents per μL in 4-5 days. The intracellular CTV progeny was already lipid-associated, suggesting that the envelope is acquired from intracellular membranes. Transmission electron microscopy of purified quasi-enveloped virus revealed exosome-like structures with an average size of 40 nm, in contrast to 27–34 nm for the non-enveloped virus. The quasi-enveloped virus was significantly less infectious than the non-enveloped virus. Assays based on quantitative RT-PCR, immunofluorescence and immunocytochemistry were established to evaluate virus inactivation. Cold ethanol fractionation removed 3.0 log of CTV and pasteurization of human albumin inactivated more than 3.7 log to below the limit of detection. Similar to HEV, virus replication was promoted in the presence of 17β-estradiol, an effect that can contribute to the understanding of the exacerbated virulence of HEV in pregnant women. These results together reveal substantial similarities between the human and fish HEV and validate CTV as a practical virus model to use in some applications for evaluating the HEV reduction capacity of biological manufacturing process steps.

2017

Delaying histone deacetylase response to injury accelerates conversion into repair Schwann cells and nerve regeneration
Scientific paper

Valérie Brügger, Mert Duman, Bochud Maëlle, Emmanuelle Münger, Manfred Heller, Sophie Ruff, Claire Jacob

Nature Communications, 2017

Link to the publication

Summary:

The peripheral nervous system (PNS) regenerates after injury. However, regeneration is often compromised in the case of large lesions, and the speed of axon reconnection to their target is critical for successful functional recovery. After injury, mature Schwann cells (SCs) convert into repair cells that foster axonal regrowth, and redifferentiate to rebuild myelin. These processes require the regulation of several transcription factors, but the driving mechanisms remain partially understood. Here we identify an early response to nerve injury controlled by histone deacetylase 2 (HDAC2), which coordinates the action of other chromatin-remodelling enzymes to induce the upregulation of Oct6, a key transcription factor for SC development. Inactivating this mechanism using mouse genetics allows earlier conversion into repair cells and leads to faster axonal regrowth, but impairs remyelination. Consistently, short-term HDAC1/2 inhibitor treatment early after lesion accelerates functional recovery and enhances regeneration, thereby identifying a new therapeutic strategy to improve PNS regeneration after lesion.

Achievements

2024

Production of a recombinant endolysin and purification of this protein

 2024 ; Process scale-up and optimization of purification technique

Collaborateurs: Bochud Maëlle

In 2024, I collaborated with Swiss-based startup Micreos, on pilot-scale production of recombinant endolysins in 5 L bioreactors for use in combatting antimicrobial resistance. This stage was a success, and the collaboration continues this year for the purification part. After successful technology transfer from their laboratories to ours, I optimised the purification method using ÄKTA Avant 150 chromatography. Still in the field of antimicrobial resistance, I recently undertook an academic exchange with Prof. Dr. Yok-ai Que's group at Inselspital in Bern to master an in vitro model (Hollow Fiber Infection Model) that mimics the in vivo pharmacodynamics/pharmacokinetics of rat models.  
I also implemented the biosafety level 2 (BSL-2) concept in our laboratories at the Biofactory Competence Center (BCC), which was accepted by the Confederation. I am now in charge of biosafety at the BCC, as well as laboratory infrastructure. I also give regularly training courses at the BCC for operators in the pharmaceutical industry and I provide training courses in downstream processing for professionals from the pharmaceutical industry.

2022

Project managment for technical production batch

 2022 ; Project organization and execution

Collaborateurs: Bochud Maëlle

During my time at Innomedica, I had the opportunity to oversee a technical production batch from start to finish. This involved participating in the process and going to the clean room. My responsibilities included modifying the master batch record, planning the necessary resources (personnel and materials), scheduling who would be in the clean room at what time and writing the report. I also collaborated with the Quality Control (QC) team to plan in-process control analyses and long-term monitoring and with the Quality Assurance (QA) team to approve all documents. This experience was very rewarding in terms of both my understanding of the entire manufacturing process and my learning of how to manage timing, supervise those involved, facilitate collaboration between teams, and plan for all eventualities — including procedures to be followed in the event of deviations.

2020

Study of cutthroat trout virus, a non-pathogenic fish hepevirus, as a potential substitute for hepatitis E virus

 2020 ; Fundamental and applied research

Collaborateurs: Bochud Maëlle

The mechanism of HEV infection remains largely unknown. This is mainly due to the lack of effective cell culture systems with which to study its biology.
For my doctoral thesis, I studied cutthroat trout virus (CTV), a non-pathogenic fish hepevirus, as a potential substitute or model for HEV. Unlike HEV, CTV replicates efficiently in cell culture, reaching titres of up to 5×10⁷ genomic equivalents per μL within 4–5 days under interferon inhibition.
My study of CTV was divided into two parts: basic research to improve our understanding of the replication cycle of the virus; and applied research involving clearing the model virus using methods such as cold ethanol fractionation, filtration and pasteurisation, which have also been tested on HEV.
Although CTV is a non-enveloped virus, I showed by transmission electron microscopy that intracellular virions are associated with lipids. This suggests that, as is the case for HEV, the envelope is acquired from intracellular membranes.
Unlike HEV, the supernatant of a CTV cell culture contains both enveloped and non-enveloped versions of the virus. Having shown that the envelope of the CTV was very stable, I demonstrated that the non-enveloped CTV did not originate from the enveloped CTV. This means that there is another egress for this form, most likely bacterial lysis.
To assess viral inactivation, I developed tests based on RT-qPCR, immunofluorescence, and immunocytochemistry. Cold ethanol fractionation resulted in a 3-log reduction and pasteurisation of human albumin inactivated more than 3.7 logs of the virus — a greater reduction than that observed for HEV.
As with HEV, CTV replication was also stimulated by 17β-estradiol, which explains the increased virulence observed in pregnant women.
These results, which show the similarities and differences between CTV and HEV, confirm that CTV can be a beneficial model for the hepavirus family, for both clearance methods and basic research.

Media and communication
Contact us
Follow the HES-SO
linkedin instagram facebook twitter youtube rss
univ-unita.eu www.eua.be swissuniversities.ch
Legal Notice
© 2021 - HES-SO.

HES-SO Rectorat